A former Astrazeneca drugs manufacturing plant that collapsed about two years after it was offloaded by the FTSE-100 company has finally been sold by the administrator.
Avlon, a 100-acre site near Bristol, which produced Crestor, Astra’s old blockbuster statin, and Seroquel, its anti-psychotic drug, has been bought from the administrator by EDC, a Canadian property company, for about £18.5 million.
EDC has brought in Maynards, an industrial auctions company, to manage the asset sales and demolition work before it redevelops the site as a warehousing and logistics park. David Rubin & Partners was appointed administrator of the site in February 2019, just over two years after Astrazeneca sold it to the start-up contract manufacturer Avara for £1.
The collapse of the factory has been highly
